BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 27476287)

  • 1. SYNTHESIS AND CYTOTOXIC ACTIVITY OF NEW 5H-INDOLO[2,3-B]QUINOLINE O-AMINOGLYCOSIDES.
    Badowska-Rosłonek K; Ciesielska A; Switalska M; Piskozub M; Peczyńska-Czoch W; Wietrzyk J; Kaczmarek Ł
    Acta Pol Pharm; 2016; 73(3):683-92. PubMed ID: 27476287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and in vitro antiproliferative activity of new 11-aminoalkylamino-substituted 5H- and 6H-indolo[2,3-b]quinolines; structure-activity relationships of neocryptolepines and 6-methyl congeners.
    Wang L; Switalska M; Mei ZW; Lu WJ; Takahara Y; Feng XW; El-Sayed Iel-T; Wietrzyk J; Inokuchi T
    Bioorg Med Chem; 2012 Aug; 20(15):4820-9. PubMed ID: 22748378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New derivatives of 11-methyl-6-[2-(dimethylamino)ethyl]-6H-indolo[2,3-b]quinoline as cytotoxic DNA topoisomerase II inhibitors.
    Luniewski W; Wietrzyk J; Godlewska J; Switalska M; Piskozub M; Peczynska-Czoch W; Kaczmarek L
    Bioorg Med Chem Lett; 2012 Oct; 22(19):6103-7. PubMed ID: 22944121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological evaluation of omega-(dialkylamino)alkyl derivatives of 6H-indolo[2,3-b]quinoline--novel cytotoxic DNA topoisomerase II inhibitors.
    Godlewska J; Luniewski W; Zagrodzki B; Kaczmarek L; Bielawska-Pohl A; Dus D; Wietrzyk J; Opolski A; Siwko M; Jaromin A; Jakubiak A; Kozubek A; Peczyñska-Czoch W
    Anticancer Res; 2005; 25(4):2857-68. PubMed ID: 16080538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and structure-activity relationship of methyl-substituted indolo[2,3-b]quinolines: novel cytotoxic, DNA topoisomerase II inhibitors.
    Peczyńska-Czoch W; Pognan F; Kaczmarek L; Boratyński J
    J Med Chem; 1994 Oct; 37(21):3503-10. PubMed ID: 7932579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quinoline derivative KB3-1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells.
    Koo JS; Choi WC; Rhee YH; Lee HJ; Lee EO; Ahn KS; Bae HS; Ahn KS; Kang JM; Choi SU; Kim MO; Lu J; Kim SH
    Life Sci; 2008 Nov; 83(21-22):700-8. PubMed ID: 18845169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxicity and cell cycle effects of novel indolo[2,3-b]quinoline derivatives.
    Humeniuk R; Kaczmarek L; Peczyńska-Czoch W; Marcinkowska E
    Oncol Res; 2003; 13(5):269-77. PubMed ID: 12688678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Searching for new derivatives of neocryptolepine: synthesis, antiproliferative, antimicrobial and antifungal activities.
    Sidoryk K; Jaromin A; Edward JA; Świtalska M; Stefańska J; Cmoch P; Zagrodzka J; Szczepek W; Peczyńska-Czoch W; Wietrzyk J; Kozubek A; Zarnowski R; Andes DR; Kaczmarek Ł
    Eur J Med Chem; 2014 May; 78():304-13. PubMed ID: 24686017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and in vitro cytotoxic effect of 6-amino-substituted 11H- and 11Me-indolo[3,2-c]quinolines.
    Wang N; Świtalska M; Wu MY; Imai K; Ngoc TA; Pang CQ; Wang L; Wietrzyk J; Inokuchi T
    Eur J Med Chem; 2014 May; 78():314-23. PubMed ID: 24686018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and anticancer evaluation of certain indolo[2,3-b]quinoline derivatives.
    Chen YL; Hung HM; Lu CM; Li KC; Tzeng CC
    Bioorg Med Chem; 2004 Dec; 12(24):6539-46. PubMed ID: 15556770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis, and biological evaluation of artemisinin-indoloquinoline hybrids as potent antiproliferative agents.
    Wang L; Świtalska M; Wang N; Du ZJ; Fukumoto Y; Diep NK; Kiguchi R; Nokami J; Wietrzyk J; Inokuchi T
    Molecules; 2014 Nov; 19(11):19021-35. PubMed ID: 25412047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of 7-oxo-7H-naphtho[1,2,3-de]quinoline derivatives as potential anticancer agents active on multidrug resistant cell lines.
    Dzieduszycka M; Bontemps-Gracz MM; Stefańska B; Martelli S; Piwkowska A; Arciemiuk M; Borowski E
    Bioorg Med Chem; 2006 May; 14(9):2880-6. PubMed ID: 16458007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, and cytotoxic activity of some novel indolo[2,3-b]quinoline derivatives: DNA topoisomerase II inhibitors.
    Kaczmarek L; Peczyńska-Czoch W; Osiadacz J; Mordarski M; Sokalski WA; Boratyński J; Marcinkowska E; Glazman-Kuśnierczyk H; Radzikowski C
    Bioorg Med Chem; 1999 Nov; 7(11):2457-64. PubMed ID: 10632055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity relationships of highly cytotoxic copper(II) complexes with modified indolo[3,2-c]quinoline ligands.
    Primik MF; Göschl S; Jakupec MA; Roller A; Keppler BK; Arion VB
    Inorg Chem; 2010 Dec; 49(23):11084-95. PubMed ID: 20979395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-Oxo-hexahydroquinoline Derivatives and Their Tetrahydroquinoline Counterparts as Multidrug Resistance Reversal Agents.
    Shahraki O; Khoshneviszadeh M; Dehghani M; Mohabbati M; Tavakkoli M; Saso L; Edraki N; Firuzi O
    Molecules; 2020 Apr; 25(8):. PubMed ID: 32316291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and anticancer activity of novel quinoline-docetaxel analogues.
    Chen M; Chen H; Ma J; Liu X; Zhang S
    Bioorg Med Chem Lett; 2014 Jul; 24(13):2867-70. PubMed ID: 24835987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methoxy- and methyl-, methoxy-5,6,11-trimethyl-6H-indolo [2,3-b]quinolinium derivatives as novel cytotoxic agents and DNA topoisomerase II inhibitors.
    Kaczmarek L; Peczyńska-Czoch W; Opolski A; Wietrzyk J; Marcinkowska E; Boratyński J; Osiadacz J
    Anticancer Res; 1998; 18(4C):3133-8. PubMed ID: 9713522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxic and multidrug resistance reversal activities of novel 1,4-dihydropyridines against human cancer cells.
    Shekari F; Sadeghpour H; Javidnia K; Saso L; Nazari F; Firuzi O; Miri R
    Eur J Pharmacol; 2015 Jan; 746():233-44. PubMed ID: 25445037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of structural modifications of anthracyclines on the ability to overcome drug resistance of cancer cells.
    Wasowska M; Wietrzyk J; Opolski A; Oszczapowicz J; Oszczapowicz I
    Anticancer Res; 2006; 26(3A):2009-12. PubMed ID: 16827137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design of antineoplastic agents based on the '2-phenylnaphthalene-type' structural pattern--synthesis and biological activity studies of 11H-indolo[3.2-c]quinoline derivatives.
    He L; Chang HX; Chou TC; Savaraj N; Cheng CC
    Eur J Med Chem; 2003 Jan; 38(1):101-7. PubMed ID: 12593920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.